title: Does long-term use of sibutramine (Meridia) result in continued weight loss in short-term responders?
authors.affiliation: University of Connecticut School of Medicine and Saint Francis Hospital and Medical Center Hartford, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Stevenson
authors.forename: T
authors.initials: T
authors.lastname: Trojian
authors.forename: E A
authors.initials: EA
authors.lastname: Jackson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001067:Appetite Depressants / Q000008:administration & dosage*; D015992:Body Mass Index; D003503:Cyclobutanes / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
chemical_list: D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine